Technical Analysis for OPGN - OpGen, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 1.76 | -7.37% | -0.14 |
Earnings due: Nov 12
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Wide Bands | Range Expansion | -7.37% | |
| Gapped Up | Strength | -7.37% | |
| Oversold Stochastic | Weakness | -7.37% | |
| New Downtrend | Bearish | -10.20% | |
| Calm After Storm | Range Contraction | -10.20% | |
| Wide Bands | Range Expansion | -10.20% | |
| Oversold Stochastic | Weakness | -10.20% | |
| 20 DMA Resistance | Bearish | -12.00% | |
| Jack-in-the-Box Bearish | Bearish Swing Setup | -12.00% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -12.00% |
| Alert | Time |
|---|---|
| Possible NR7 | about 24 hours ago |
| Down 5% | 1 day ago |
| Down 3% | 1 day ago |
| Fell Below Previous Day's Low | 1 day ago |
| Down 2 % | 1 day ago |
Get a Trading Sidekick!
- Earnings date: 11/12/2024
OpGen, Inc. Description
OpGen, Inc. operates as an early commercial stage company using molecular testing and bioinformatics to assist healthcare providers to combat multi-drug-resistant bacterial infections. It offers Acuitas multi-drug-resistant organisms (MDRO) gene test, a molecular screening tool that detects 10 critical MDRO genes from 1 patient swab. The company also provides Acuitas CR Elite Test, which adds the ability to procure a standard microbiological culture result that provides additional information about the identified MDRO gene and its antibiotic susceptibility profile. In addition, it develops Acuitas Lighthouse MDRO bioinformatics product, which focuses on providing MDRO molecular information about an individual patient's resistance profile. OpGen, Inc. has a strategic collaboration with Hitachi High-Technologies Corporation to commercialize its genome mapping technology for mapping, assembly, and analysis of human DNA. The company was incorporated in 2001 and is headquartered in Gaithersburg, Maryland.
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Healthcare Providers Antibiotics Genome Informatics Bacterial Infections Bioinformatics Veterinary Medicine Organisms Bacteria Antimicrobial Resistance Evolutionary Biology Multi Drug Resistant Bacterial Infections
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 38.4 |
| 52 Week Low | 1.65 |
| Average Volume | 19,086 |
| 200-Day Moving Average | 4.09 |
| 50-Day Moving Average | 2.62 |
| 20-Day Moving Average | 2.42 |
| 10-Day Moving Average | 2.11 |
| Average True Range | 0.27 |
| RSI (14) | 26.47 |
| ADX | 30.75 |
| +DI | 17.33 |
| -DI | 18.10 |
| Chandelier Exit (Long, 3 ATRs) | 2.29 |
| Chandelier Exit (Short, 3 ATRs) | 2.63 |
| Upper Bollinger Bands | 3.21 |
| Lower Bollinger Band | 1.62 |
| Percent B (%b) | 0.17 |
| BandWidth | 65.69 |
| MACD Line | -0.24 |
| MACD Signal Line | -0.21 |
| MACD Histogram | -0.0393 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 2.20 | ||||
| Resistance 3 (R3) | 2.23 | 2.17 | 2.15 | ||
| Resistance 2 (R2) | 2.17 | 2.09 | 2.15 | 2.13 | |
| Resistance 1 (R1) | 2.03 | 2.04 | 2.00 | 2.00 | 2.12 |
| Pivot Point | 1.97 | 1.97 | 1.95 | 1.95 | 1.97 |
| Support 1 (S1) | 1.83 | 1.89 | 1.80 | 1.80 | 1.68 |
| Support 2 (S2) | 1.77 | 1.84 | 1.75 | 1.67 | |
| Support 3 (S3) | 1.63 | 1.77 | 1.65 | ||
| Support 4 (S4) | 1.60 |
